SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-171482
Filing Date
2008-08-08
Accepted
2008-08-08 12:29:19
Documents
7
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 435751
2 AMENDMENT NO. 8 TO EXCLUSIVE LICENSE AGREEMENT AND LETTER AGREEMENT dex101.htm EX-10.1 18744
3 THIRD AMENDMENT TO LEASE dex102.htm EX-10.2 16836
4 AMENDMENT TO EXHIBIT A-5 dex103.htm EX-10.3 61379
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9341
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9296
7 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 4482
  Complete submission text file 0001193125-08-171482.txt   557243
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 081001385
SIC: 2836 Biological Products, (No Diagnostic Substances)